LEXINGTON, Mass.–(Business Wire)–
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that management will
present at the following investor conferences during the month of June:
* June 9, at 8:00 a.m. ET – 9th Annual Needham Healthcare Conference in New York
* June 10, at 4:30 p.m. ET – Jefferies 2010 Global Life Sciences Conference in
New York City; and
* June 15, at 2:30 p.m. PT – Goldman Sachs 31st Annual Global Healthcare
Conference in Los Angeles, CA.
Live webcasts of each presentation will be accessible through the Investors
section of the company`s website at www.amagpharma.com. Following each
conference, the webcast will be archived on the AMAG Pharmaceuticals, Inc.
website for approximately two weeks.
About AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company that utilizes its
proprietary technology for the development and commercialization of a
therapeutic iron compound to treat iron deficiency anemia and novel imaging
agents to aid in the diagnosis of cancer and cardiovascular disease. On June 30,
2009, AMAG received approval from the U.S. Food and Drug Administration to
market Feraheme® (ferumoxytol) Injection for intravenous (IV) use for the
treatment of iron deficiency anemia in adult chronic kidney disease patients.
For additional company and product information, please visit www.amagpharma.com.
Feraheme is a registered trademark of AMAG Pharmaceuticals, Inc.
Carol Miceli, 617-498-3361
Copyright Business Wire 2010